UBS Maintains Neutral on Corteva, Raises Price Target to $90
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $85 to $90.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $85 to $90.